Werner Kramer
Aventis Pharma Deutschland GmbH
Disease Group Metabolic Diseases
D-65926
Frankfurt am Main
Germany
Name/email consistency: high
- Aminopeptidase N (CD13) is a molecular target of the cholesterol absorption inhibitor ezetimibe in the enterocyte brush border membrane. Kramer, W., Girbig, F., Corsiero, D., Pfenninger, A., Frick, W., Jähne, G., Rhein, M., Wendler, W., Lottspeich, F., Hochleitner, E.O., Orsó, E., Schmitz, G. J. Biol. Chem. (2005)
- Intestinal cholesterol absorption: identification of different binding proteins for cholesterol and cholesterol absorption inhibitors in the enterocyte brush border membrane. Kramer, W., Girbig, F., Corsiero, D., Burger, K., Fahrenholz, F., Jung, C., Müller, G. Biochim. Biophys. Acta (2003)
- Identification of the bile acid-binding site of the ileal lipid-binding protein by photoaffinity labeling, matrix-assisted laser desorption ionization-mass spectrometry, and NMR structure. Kramer, W., Sauber, K., Baringhaus, K.H., Kurz, M., Stengelin, S., Lange, G., Corsiero, D., Girbig, F., König, W., Weyland, C. J. Biol. Chem. (2001)
- Identification of a ligand-binding site in the Na+/bile acid cotransporting protein from rabbit ileum. Kramer, W., Girbig, F., Glombik, H., Corsiero, D., Stengelin, S., Weyland, C. J. Biol. Chem. (2001)
- Identification of binding proteins for cholesterol absorption inhibitors as components of the intestinal cholesterol transporter. Kramer, W., Glombik, H., Petry, S., Heuer, H., Schäfer, H., Wendler, W., Corsiero, D., Girbig, F., Weyland, C. FEBS Lett. (2000)
